Nanoscope's Clinical and Scientific Advancesin Optogenetics to be Featured at ASGCT Annual Meeting, May 16-19, 2022 in Washington, DC

/PRNewswire/ -- Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing optogenetic therapies for treatment of retinal degenerative...

Related Keywords

Washington ,District Of Columbia ,United States ,Dallas ,Texas ,American ,Subrata Batabyal ,Psulagna Bhattacharya ,Samarendra Mohanty ,Dan Eramian ,Darryl Narcisse ,Sanghoon Kim ,Prnewswire Nanoscope Therapeutics Inc ,Opus Biotech Communications ,Waltere Washington Convention Center ,Meeting Of The American Society Gene ,Nanoscope Therapeutics Inc ,Therapeutics Inc ,Annual Meeting ,American Society ,Cell Therapy ,Convention Center ,Nanoparticle Based Gene Transfer ,Vivo Spatially Targeted Nonviral Optical Delivery ,Auditory Diseases ,Central Nervous System ,Cell Therapy Trials ,Nanoscope Therapeutics ,